Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly
in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic …

Background We systematically reviewed the existing literature on the cosmetic adverse
effects of antiseizure medications (ASMs) in order to depict a clear picture of these unwanted …

Objective Reports about medication adherence and satisfaction in patients with epilepsy in
Arab countries are lacking. The objective of this study was to assess medication adherence …

OBJECTIVES: Excessive weight gain associated with valproate sodium (VPA) may
predispose patients with epilepsy to other health problems such as insulin resistance. The …

Epilepsy is known to be associated with multiple psychiatric comorbidities, such as
depression, sleep-disorders, and anxiety. The objective of this study was to determine the …

Purpose We systematically reviewed studies to provide current evidence about the
incidence and risk of alopecia in patients undergoing valproic acid (VPA) therapy. Methods …

Background: Epilepsy is defined as recurrent unprovoked febrile seizures, which cause
disability in patients. This study aims to assess the health-related quality-of-life (QOL) in …

Introducción. La calidad de vida (CdV) percibida por las personas con epilepsia ha
demostrado ser un factor relevante para la continuidad en el tratamiento y en la percepción …

Objectives We aimed to translate and validate a short-form of Quality of Life Inventory in
Epilepsy-89 (QOLIE-89)–QOLIE-10 for use in the busy clinical setting. Methods Accepted …

Introducción: en el mundo aproximadamente 50 millones de personas presentan epilepsia,
La enfermedad genera una gran secuela en el paciente, y en las familias con esta …